The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

NCT01901341 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
44
Enrollment
INDUSTRY
Sponsor class

Stopped Due to difficulties with enrollment, the study was terminated early.

Conditions

Interventions

Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)